DURATION OF REHABILITATION THERAPY TO ACHIEVE A MINIMAL CLINICALLY IMPORTANT DIFFERENCE IN MOBILITY, WALKING ENDURANCE AND PATIENT-REPORTED PHYSICAL HEALTH: AN OBSERVATIONAL STUDY

Objective: To compare the duration of exercise the-rapy needed to achieve a minimal clinically important difference in mobility, walking endurance and patient-reported global physical health in patients referred for inpatient rehabilitation after knee surgery, hip sur-gery, or with multiple sclerosis or Parkinson's disease. Design: Retrospective pre-post intervention obser-vational cohort study. Subjects: A total of 388 patients (57% women, mean age 65.6 years (standard deviation 9.5)) with a minimum length of stay 10 days were inclu-ded between 1 January 2020 and 30 April 2021. Methods: Outcomes were assessed at the start of, and discharge from, rehabilitation, using the following measures: mobility (Timed Up and Go test), walking endurance (6-minute walk test), patient-reported global physical health (Global Physical Health subscale of the 10-item Patient-Reported Out-comes Measurement Information System). The dura-tion of exercise therapy needed to achieve a minimal clinically important difference was determined using anchor-based and distribution-based methods. Results: The duration of therapy needed to achieve a minimal clinically important difference was longer in patients with multiple sclerosis or Parkinson's disease (18-88 h) than in patients after knee or hip surgery (8-25 h). In all patient groups, the duration of exercise therapy needed, determined using the distribution-based method, was shortest for patient-reported global physical health (knee surgery 9.6 h, hip surgery 6.8 h, multiple sclerosis 38.7 h, Parkinson's disease 18.4 h). Conclusion: The duration of active therapies required to achieve a minimal clinically important difference in physical outcomes varies widely (range 8-88 h) among different patient groups and outcomes.

Automated summary

This study compares the duration of exercise therapy required to achieve a minimal clinically important difference in physical outcomes among patients undergoing knee surgery, hip surgery, or with multiple sclerosis or Parkinson's disease. The results indicate significant differences in therapy duration among different patient groups and outcomes.